Inappropriate medication use and polypharmacy in older people
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m2023 (Published 18 June 2020) Cite this as: BMJ 2020;369:m2023Linked Research
Use of an electronic decision support tool to reduce polypharmacy in elderly people with chronic diseases
Linked Opinion
Reduction of polypharmacy by electronic decision support—less is more
- Doron Garfinkel, head1,
- Aaron Bilek, doctor2
- 1Center for Appropriate Medication Use, Sheba Medical Center, Tel Hashomer, Israel
- 2Geriatric division, Tel Aviv Sourasky Medical Center, Israel
- Correspondence to: D Garfinkel dgarfink{at}netvision.net.il
Inappropriate medication use and polypharmacy is widespread yet continues to receive precious little attention.12 And, despite countless people being affected, particularly in older populations, no general consensus exists on the best way to combat this insidious problem.23
In a linked study, Rieckert and colleagues (doi:10.1136/bmj.m1822) present the results of a large randomised controlled trial in primary care in Austria, Germany, Italy, and the United Kingdom that evaluated the performance of PRIMA-eDS (polypharmacy in chronic diseases: reduction of inappropriate medication and adverse drug events in older populations by electronic decision support), a computerised tool providing individualised evidence based recommendations on deprescribing.4 Use of this tool for patients aged 75 and older who were taking at least eight drugs each resulted in a reduction of 0.42 drugs per patient and a modest risk reduction in mortality and admission to hospital. Although the intervention had no effect on other clinical outcomes …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.